<table class="naaccr-summary-table naaccr-borders">
  <tr>
    <th class="naaccr-summary-header naaccr-borders">Item #</th>
    <th class="naaccr-summary-header naaccr-borders">Length</th>
    <th class="naaccr-summary-header naaccr-borders">Source of Standard</th>
    <th class="naaccr-summary-header naaccr-borders">Year Implemented</th>
    <th class="naaccr-summary-header naaccr-borders">Version Implemented</th>
    <th class="naaccr-summary-header naaccr-borders">Year Retired</th>
    <th class="naaccr-summary-header naaccr-borders">Version Retired</th>
  </tr>
  <tr>
    <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered">776</td>
    <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered">2</td>
    <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered">SEER</td>
    <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered">2018</td>
    <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered">16</td>
    <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered"></td>
    <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered"></td>
  </tr>
</table>

<br/><strong>NAACCR XML</strong>: Tumor.eodMets<br/><br/>
<strong>Alternate Names</strong>
<br/>&nbsp;&nbsp;&nbsp;SEER Mets

<div class='content chap10-para-head'><strong>Description</strong></div>
<div class='content chap10-para'>
<p>EOD Mets is part of the EOD 2018 data collection system and is used to classify the distant site(s) of metastatic involvement at time of diagnosis. See also EOD Primary Tumor [772] and EOD Regional Nodes [774]. Effective for cases diagnosed 1/1/2018+.</p>

</div>

<div class='content chap10-para-head'><strong>Rationale</strong></div>
<div class='content chap10-para'>
<p>EOD Mets is used to calculate Derived EOD 2018 M [795] (when applicable) and Derived Summary Stage 2018 [762]. Derivation will occur at the level of the central registry.</p>

</div>


<div class='content chap10-para'>
<p><em>Note</em>: This data item was included in Standards Volume II, Version 16; however, it was not implemented until 2018.</p>

</div>

<div class='content chap10-para'><p><strong>Codes (in addition to valid schema-specific codes)</strong></p>
</div>
<table>
        <tr class='code-row'><td class='code-nbr'>00</td><td class='code-desc'>None  
 No distant metastasis  
 Unknown if distant metastasis</td></tr>
        <tr class='code-row'><td class='code-nbr'>88</td><td class='code-desc'>Not applicable: Information not collected for this schema  
 Use for these sites only: HemeRetic;   
Ill Defined Other (includes unknown primary site);   
Kaposi Sarcoma;   
Lymphoma;   
Lymphoma-CLL/SLL;   
Myeloma Plasma Cell Disorder</td></tr>
        <tr class='code-row'><td class='code-nbr'>99</td><td class='code-desc'>Death certificate only (DCO)</td></tr>
</table>

<div class='content chap10-para'>
<p><em>Note</em>: See the most current version of EOD (<a href="https://staging.seer.cancer.gov/">https://staging.seer.cancer.gov/</a>) for rules and site-specific codes and coding structures.</p>

</div>
